Volume 15, Number 3—March 2009
CME ACTIVITY - Research
Clinical Risk Factors for Severe Clostridium difficile–associated Disease
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Medscape, LLC designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at http://www.medscape.com/cme/eid; (4) view/print certificate.
Upon completion of this activity, participants will be able to:
- Identify the criteria used to define severe Clostridium difficile–associated disease (CDAD) in the current study
- Specify the prevalence of severe CDAD in the current study
- Identify the clinical risk factors for severe CDAD
- List the laboratory risk factors for severe CDAD
Lynne Stockton, Technical Writer-Editor, Emerging Infectious Diseases. Disclosure: Lynne Stockton has disclosed no relevant financial relationships.
Charles P. Vega, MD, Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.
Disclosures: Timothy J. Henrich, MD; Douglas Krakower, MD; Asaf Bitton, MD; and Deborah S. Yokoe, MD, MPH, have disclosed no relevant financial relationships.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: December 07, 2010
- Page last updated: December 07, 2010
- Page last reviewed: December 07, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)